Actos Buyers Fight Takeda Appeal Bid In Drug Delay Case

By Christopher Cole (December 16, 2019, 6:03 PM EST) -- End payors and direct buyers of the diabetes drug Actos have urged a New York federal judge to nix Takeda's bid to immediately appeal her decision preserving some class action claims against the drugmaker, which they have accused of using patent suits to hold off generic competitors....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!